|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
REBEC |
|
Last refreshed on:
|
29 April 2013 |
|
Main ID: |
RBR-2c236v |
|
Date of registration:
|
01/09/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Lower third molar removal with 2% articaine.
|
|
Scientific title:
|
Evaluation of the anesthetic efficacy and
hemodynamic effects in the use of 2% and
4% articaine associated with 1:200,000
epinephrine in lower third molar removals. |
|
Date of first enrolment:
|
01/07/2011 |
|
Target sample size:
|
50 |
|
Recruitment status: |
not yet recruiting |
|
URL:
|
http://www.ensaiosclinicos.gov.br/rg/RBR-2c236v/ |
|
Study type:
|
|
|
Study design:
|
Clinical double-blind, randomizedcontrolled, cross-over study.
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
Carlos
Santos |
|
Address:
|
17012-901
Bauru
Brazil |
|
Telephone:
|
(14)32358276 |
|
Email:
|
cebola@usp.br |
|
Affiliation:
|
Faculdade de Odontologia de Bauru - Universidade de São Paulo |
|
|
Name:
|
Carlos
Santos |
|
Address:
|
17012-901
Bauru
Brazil |
|
Telephone:
|
(14)32358276 |
|
Email:
|
cebola@usp.br |
|
Affiliation:
|
Faculdade de Odontologia de Bauru - Universidade de São Paulo |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Precise indication of removal of the two
lower third molars in similar positions in the same volunteer, as observed on panoramic radiograph;
All patients will provide written informed
consent during the pretreatment screening period before any study procedures are performed. The patients will be randomly selected regarding gender. The minimum age for inclusion in the study will be 18 years old and the maximum 45 years old.
Exclusion criteria: Presence of systemic diseases;
Presence of local inflammation and/or
infection;
Any history of allergic reaction to local
anesthetics, gastrointestinal bleeding or
ulceration;
Cardiovascular and kidney diseases;
Asthma and allergy to aspirin, piroxicam or
any other non-steroidal antiinflammatory
drug;
Regular use of any non-steroidal
antiinflammatory drug, pregnancy or breast feeding.
Age minimum:
18Y
Age maximum:
45Y
Gender:
-
|
|
Health Condition(s) or Problem(s) studied
|
Local anesthesia during lower third molar
removals. K10.9 K11.8
|
|
Intervention(s)
|
Group I: 50 patients, after randomization of the local anesthetic solution, will undergo unilateral lower third molar extraction with 2% or 4% articaine (with 1:200,000 epinephrine), in the dose of 54 mg or 108 mg, respectively (one and a half cartridge), in a double-blind manner. Group II: One to two months after the first extraction, the same 50 patients in Group I will undergo extraction of the contralateral lower third molar with the local anesthetic not used in the first extraction, in the dose of 54 mg or 108 mg, respectively (one and a half cartridge), of 2% or 4% articaine (with 1:200,000 epinephrine).
|
|
Primary Outcome(s)
|
For each surgical procedure the following parameters will be assessed: Total volume of anesthetic solution used during the surgery (in mL). Onset of anesthetic agent action (latency, in minutes), as determined by the loss of sensibility of the inferior lip, the corresponding half of the tongue, and the mucosa as reported by the patient. Quality of the anesthesia provided by the local anesthetic during the surgery and evaluated by the surgeon, according to a modification of the method described by Sisk (1986), based on a 3-point category rating scale: 1) no discomfort reported by the patient during the surgery; 2) any discomfort reported by patient during the surgery, without the need for additional anesthesia; and 3) any discomfort reported by patient during the surgery, with the need of additional anesthesia. Difficulty of the surgery according to the surgical trauma, rated by the surgeon at the completion of each extraction, according to a 3-point category rating scale: 1: easy; 2: normal; 3: complicated. Duration of the surgery (in minutes), corresponding to the period between the first incision and the final suture. Duration of postoperative analgesia (in minutes), as determined by the difference between the time at the end of the surgery and that at ingestion of the first piroxicam capsule for pain relief, recorded by the patient in a specific chart that will be provided. Duration of postoperative anesthesia (in minutes), represented by the lack of sensibility of the mucosa, tongue, and inferior lip after the surgery. Patients will record the moment that the anesthetic had worn off in a specific chart that will be provided. Intraoperative bleeding, rated by the surgeon according to a 3-point category rating scale (1: minimal bleeding; 2: normal bleeding; 3: excessive bleeding) (Sisk, 1986), immediately after the following steps: injection of the first cartridge of articaine, tissue incision, flap reflection, osteotomy, tooth sectioning, extraction, cleaning of the surgical place and stitches. Systolic, diastolic, and mean arterial pressure; heart rate; and oxygen saturation, measured before the surgery and immediately after the steps described in item 8. All of the measurements will be automated and noninvasive, performed with a device for monitoring hemodynamic parameters (DX2010; Dixtal Biomédica Ind e Com Ltda, Marília/SP, Brazil) according to the manufacturer's instructions.
|
|
Secondary ID(s)
|
|
CAAE-0106.0.224.000-09
|
|
Source(s) of Monetary Support
|
|
Fundação de Amparo à Pesquisa do Estado de São Paulo - Brazil
|
|